Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trialUwe Platzbecker, Christian Thiede, Uta Oelschlaegel et al.|Leukemia|2011Cited by 398
Combining SDF-1/CXCR4 antagonism and chemotherapy in relapsed acute myeloid leukemiaFernando A. Fierro, Martin Bornhäuser, Sebastian Brenner et al.|Leukemia|2008Cited by 30